Detailed price information for Theralase Technologies Inc (TLT-X) from The Globe and Mail including charting and trades.
Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that European Urology Oncology published results of a clinical study demonstrating ...
Adding Bladder EpiCheck to cystoscopy for non-muscle invasive bladder cancer (NMIBC) surveillance and, if positive, performing biopsy under photodynamic diagnosis (PDD), significantly improved ...
In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...
DuBOIS — Drs. Indraneel Banerjee and John S. Banerji, urologists at Penn Highlands Urology in DuBois, have reached a significant milestone in patients’ health. A milestone 100 in-office cystoscopy ...
from 2009-2022 assessing patients treated with BCG for primary NMIBC. In the study, 4318 patients from the Danish registry were identified with a first-time NMIBC diagnosis that were treated with BCG.
A urine test was shown to decrease the need for invasive cystoscopies in patients with non-muscle-invasive bladder cancer. A urine-based test may decrease the number of invasive cystoscopies in ...
“The actions taken by those matched over 80% of the time. It seemed like what they saw, knowing the history, was a reasonable approximation of what an in-person urologist would do,” says Tracey L.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results